Clinical research on the combined treatment of 283 cases of chronic bacterial prostatitis
MIN Li-gui,TANG Ze-tian,JIA Hong-liang(Department of Urology & Andrology,People's Hospital of Xinjiang Uygur Autonomous Region,Urumqi 830001,China)
Objective To evaluate the effects of combined therapy for chronic bacterial prostatitis. Methods A total of 283 patients with chronic bacterial prostatitis were randomly divided into 3 groups: the combined treatment group including 95 patients who underwent combination of antibiotherapy and antibiotic injection in prostate;the antibiotic group including 94 patients;the Chinese patent medicine group including 94 patients. The treatment course for each group was 2 months. The follow up lasted for 1～3 months. The therapeutic effects of the 3 therapies were compared and analyzed. Results In the 3 groups,the average scores of chronic prostatitis symptom index (CPSI) were reduced from 19.4±5.2,16.3±5.6,and 15.3±6.2 before treatment to 5.2±3.2,10.2±2.2 and 13.2±3.2 after treatment. After 8 weeks of treatment,the number of the patients,with normal EPS (WBC10/HP) was 75(78.99%),48(51%),and 32(32.2%) in the combined treatment group,antibiotic group,and Chinese patent medicine group respectively. The bacterium negative rate in the combined treatment group,antibiotic group,and Chinese patent medicine group was 85(89.5%),64(68%),and 24(23.9%) respectively. There was significant difference between the combined therapy group and the other two control groups (P0.01). Conclusion The curative effect of combined therapy was satisfactory and significantly better than that of the single-method therapy.